Listed

Angiodynamics Inc: Form 10-Q for the period ended Feb 29, 2012

Filed with the SEC on Apr 9, 2012 and accepted by EDGAR at Apr 9, 2012, 16:00 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2012-02-29. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2011-12-01 to 2012-02-29$51.6mus-gaap:SalesRevenueNet
Revenue9 months2011-06-01 to 2012-02-29$164.1mus-gaap:SalesRevenueNet
Cost of revenue3 months2011-12-01 to 2012-02-29$22.2mus-gaap:CostOfGoodsSold
Cost of revenue9 months2011-06-01 to 2012-02-29$69.3mus-gaap:CostOfGoodsSold
Gross profit3 months2011-12-01 to 2012-02-29$29.4mus-gaap:GrossProfit
Gross profit9 months2011-06-01 to 2012-02-29$94.8mus-gaap:GrossProfit
Research and development3 months2011-12-01 to 2012-02-29$4.6mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2011-06-01 to 2012-02-29$15.3mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2011-12-01 to 2012-02-29−$2.8mus-gaap:OperatingIncomeLoss
Operating income9 months2011-06-01 to 2012-02-29$3.9mus-gaap:OperatingIncomeLoss
Interest expense3 months2011-12-01 to 2012-02-29$102.0kus-gaap:InterestExpense
Interest expense9 months2011-06-01 to 2012-02-29$329.0kus-gaap:InterestExpense
Income tax3 months2011-12-01 to 2012-02-29−$1.1mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2011-06-01 to 2012-02-29$858.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2011-12-01 to 2012-02-29−$1.8mus-gaap:NetIncomeLoss
Net income9 months2011-06-01 to 2012-02-29$1.9mus-gaap:NetIncomeLoss
Diluted EPS3 months2011-12-01 to 2012-02-29−$0.07us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2011-06-01 to 2012-02-29$0.08us-gaap:EarningsPerShareDiluted
Basic EPS3 months2011-12-01 to 2012-02-29−$0.07us-gaap:EarningsPerShareBasic
Basic EPS9 months2011-06-01 to 2012-02-29$0.08us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2011-12-01 to 2012-02-2925,129,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2011-06-01 to 2012-02-2925,289,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2011-06-01 to 2012-02-29$12.5mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2011-06-01 to 2012-02-29$1.9mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2012-02-29$34.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2012-02-29$211.0mus-gaap:AssetsCurrent
Total assetsAt period end2012-02-29$446.6mus-gaap:Assets
Current liabilitiesAt period end2012-02-29$29.2mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2012-02-29$35.2mus-gaap:Liabilities
Long-term debtAt period end2012-02-29$6.0mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2012-02-29$295.0kus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2012-02-29$411.4mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001193125-12-155135. Last ingested by Listed: Nov 4, 2026, 20:24 ET. Listed shows no prices and gives no investment advice.